The chemokine receptor CCR5 plays a role in post-traumatic cartilage loss in mice, but does not affect synovium and bone

Osteoarthritis and Cartilage

Volumn 23, Issue 3, 2015, Pages 454-461

  Takebe, K ^a   Rai, M F ^a   Schmidt, E J ^a   Sandell, L J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone; Cartilage; CCR5; Osteoarthritis; Post traumatic; Synovium

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CCR5 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; BODY WEIGHT; BONE; CARTILAGE DEGENERATION; CONTROLLED STUDY; HISTOPATHOLOGY; KNEE INJURY; KNEE MENISCUS; MOUSE; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; OSTEOARTHRITIS; PHENOTYPE; PRIORITY JOURNAL; SYNOVITIS; SYNOVIUM; ANIMAL; COMPLICATION; DISEASE MODEL; FEMUR; GENETICS; INJURIES; KNOCKOUT MOUSE; MICRO-COMPUTED TOMOGRAPHY; OSTEOARTHRITIS, KNEE; PATHOLOGY; RADIOGRAPHY; TIBIA;

ANIMALS; CARTILAGE, ARTICULAR; DISEASE MODELS, ANIMAL; FEMUR; KNEE INJURIES; MENISCI, TIBIAL; MICE; MICE, KNOCKOUT; OSTEOARTHRITIS, KNEE; RECEPTORS, CCR5; SYNOVIAL MEMBRANE; TIBIA; X-RAY MICROTOMOGRAPHY;

EID: 84924931349     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2014.12.002     Document Type: Article

References (46)

1. Sniekers Y.H., Intema F., Lafeber F.P., van Osch G.J., van Leeuwen J.P., Weinans H., et al. Arole for subchondral bone changes in the process of osteoarthritis; a micro-CT study of two canine models. BMC Musculoskelet Disord 2008, 9:20.
2. Goldring M.B., Goldring S.R. Osteoarthritis. JCell Physiol 2007, 213:626-634.
3. Fernandes J.C., Martel-Pelletier J., Pelletier J.P. The role of cytokines in osteoarthritis pathophysiology. Biorheology 2002, 39:237-246.
4. Loeser R.F., Goldring S.R., Scanzello C.R., Goldring M.B. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 2012, 64:1697-1707.
5. Lorenz H., Richter W. Osteoarthritis: cellular and molecular changes in degenerating cartilage. Prog Histochem Cytochem 2006, 40:135-163.
6. Attur M.G., Dave M., Akamatsu M., Katoh M., Amin A.R. Osteoarthritis or osteoarthrosis: the definition of inflammation becomes a semantic issue in the genomic era of molecular medicine. Osteoarthritis Cartilage 2002, 10:1-4.
7. Goldring M.B. Osteoarthritis and cartilage: the role of cytokines. Curr Rheumatol Rep 2000, 2:459-465.
8. Vergunst C.E., van de Sande M.G., Lebre M.C., Tak P.P. The role of chemokines in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 2005, 34:415-425.
9. Borzi R.M., Mazzetti I., Marcu K.B., Facchini A. Chemokines in cartilage degradation. Clin Orthop Relat Res 2004, S53-S61.
10. Gerard C., Rollins B.J. Chemokines and disease. Nat Immunol 2001, 2:108-115.
11. Balistreri C.R., Caruso C., Grimaldi M.P., Listi F., Vasto S., Orlando V., et al. CCR5 receptor: biologic and genetic implications in age-related diseases. Ann N Y Acad Sci 2007, 1100:162-172.
12. Weiss I.D., Shoham H., Wald O., Wald H., Beider K., Abraham M., et al. Ccr5 deficiency regulates the proliferation and trafficking of natural killer cells under physiological conditions. Cytokine 2011, 54:249-257.
13. Zhang Z., Bryan J.L., DeLassus E., Chang L.W., Liao W., Sandell L.J. CCAAT/Enhancer-binding protein {beta} and NF-{kappa}B mediate high level expression of chemokine genes CCL3 and CCL4 by human chondrocytes in response to IL-1{beta}. JBiol Chem 2010, 285:33092-33103.
14. Sandell L.J., Xing X., Franz C., Davies S., Chang L.W., Patra D. Exuberant expression of chemokine genes by adult human articular chondrocytes in response to IL-1beta. Osteoarthritis Cartilage 2008, 16:1560-1571.
15. Zhang Z., Xing X., Hensley G., Chang L.W., Liao W., Abu-Amer Y., et al. Resistin induces expression of proinflammatory cytokines and chemokines in human articular chondrocytes via transcription and messenger RNA stabilization. Arthritis Rheum 2010, 62:1993-2003.
16. Haas C.S., Martinez R.J., Attia N., Haines G.K., Campbell P.L., Koch A.E. Chemokine receptor expression in rat adjuvant-induced arthritis. Arthritis Rheum 2005, 52:3718-3730.
17. Shahrara S., Proudfoot A.E., Woods J.M., Ruth J.H., Amin M.A., Park C.C., et al. Amelioration of rat adjuvant-induced arthritis by Met-RANTES. Arthritis Rheum 2005, 52:1907-1919.
18. Okamoto H., Kamatani N. ACCR-5 antagonist inhibits the development of adjuvant arthritis in rats. Rheumatology (Oxford) 2006, 45:230-232.
19. Yuan G.H., Masuko-Hongo K., Sakata M., Tsuruha J., Onuma H., Nakamura H., et al. The role of C-C chemokines and their receptors in osteoarthritis. Arthritis Rheum 2001, 44:1056-1070.
20. Borzi R.M., Mazzetti I., Cattini L., Uguccioni M., Baggiolini M., Facchini A. Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines. Arthritis Rheum 2000, 43:1734-1741.
21. Alaaeddine N., Olee T., Hashimoto S., Creighton-Achermann L., Lotz M. Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation. Arthritis Rheum 2001, 44:1633-1643.
22. Qin S., Rottman J.B., Myers P., Kassam N., Weinblatt M., Loetscher M., et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. JClin Invest 1998, 101:746-754.
23. Haringman J.J., Smeets T.J., Reinders-Blankert P., Tak P.P. Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. Ann Rheum Dis 2006, 65:294-300.
24. Tang C.H., Hsu C.J., Fong Y.C. The CCL5/CCR5 axis promotes interleukin-6 production in human synovial fibroblasts. Arthritis Rheum 2010, 62:3615-3624.
25. Suzuki N., Nakajima A., Yoshino S., Matsushima K., Yagita H., Okumura K. Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis. Int Immunol 1999, 11:553-559.
26. Yamada H., Nakashima Y., Okazaki K., Mawatari T., Fukushi J., Oyamada A., et al. Preferential accumulation of activated Th1 cells not only in rheumatoid arthritis but also in osteoarthritis joints. JRheumatol 2011, 38:1569-1575.
27. Doodes P.D., Cao Y., Hamel K.M., Wang Y., Rodeghero R.L., Kobezda T., et al. CCR5 is involved in resolution of inflammation in proteoglycan-induced arthritis. Arthritis Rheum 2009, 60:2945-2953.
28. Glasson S.S., Blanchet T.J., Morris E.A. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage 2007, 15:1061-1069.
29. Hashimoto S., Rai M.F., Janiszak K.L., Cheverud J.M., Sandell L.J. Cartilage and bone changes during development of post-traumatic osteoarthritis in selected LGXSM recombinant inbred mice. Osteoarthritis Cartilage 2012, 20:562-571.
30. Glasson S.S., Chambers M.G., Van Den Berg W.B., Little C.B. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage 2010, 18(Suppl 3):S17-S23.
31. Lewis J.S., Hembree W.C., Furman B.D., Tippets L., Cattel D., Huebner J.L., et al. Acute joint pathology and synovial inflammation is associated with increased intra-articular fracture severity in the mouse knee. Osteoarthritis Cartilage 2011, 19:864-873.
32. -/- mice have less subchondral bone changes after induction of osteoarthritis through surgical instability: implications for a link between cartilage and subchondral bone changes. Osteoarthritis Cartilage 2009, 17:636-645.
33. Bouxsein M.L., Boyd S.K., Christiansen B.A., Guldberg R.E., Jepsen K.J., Muller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. JBone Miner Res 2010, 25:1468-1486.
34. Patel V., Issever A.S., Burghardt A., Laib A., Ries M., Majumdar S. MicroCT evaluation of normal and osteoarthritic bone structure in human knee specimens. JOrthop Res 2003, 21:6-13.
35. Scanzello C.R., Goldring S.R. The role of synovitis in osteoarthritis pathogenesis. Bone 2012, 51:249-257.
36. Howell D.S. Pathogenesis of osteoarthritis. Am J Med 1986, 80:24-28.
37. Sandell L.J., Aigner T. Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthritis Res 2001, 3:107-113.
38. Attur M., Samuels J., Krasnokutsky S., Abramson S.B. Targeting the synovial tissue for treating osteoarthritis (OA): where is the evidence?. Best Pract Res Clin Rheumatol 2010, 24:71-79.
39. Vierboom M.P., Zavodny P.J., Chou C.C., Tagat J.R., Pugliese-Sivo C., Strizki J., et al. Inhibition of the development of collagen-induced arthritis in rhesus monkeys by a small molecular weight antagonist of CCR5. Arthritis Rheum 2005, 52:627-636.
40. Yang Y.F., Mukai T., Gao P., Yamaguchi N., Ono S., Iwaki H., et al. Anon-peptide CCR5 antagonist inhibits collagen-induced arthritis by modulating T cell migration without affecting anti-collagen T cell responses. Eur J Immunol 2002, 32:2124-2132.
41. Whiteley P.E., Dalrymple S.A. Models of inflammation: adjuvant-induced arthritis in the rat. Curr Protoc Pharmacol 2001, Chapter 5: Unit5.5.
42. Williams R.O. Collagen-induced arthritis as a model for rheumatoid arthritis. Methods Mol Med 2004, 98:207-216.
43. Moreno C., Nicaise C., Gustot T., Quertinmont E., Nagy N., Parmentier M., et al. Chemokine receptor CCR5 deficiency exacerbates cerulein-induced acute pancreatitis in mice. Am J Physiol Gastrointest Liver Physiol 2006, 291:G1089-G1099.
44. Lisignoli G., Toneguzzi S., Pozzi C., Piacentini A., Grassi F., Ferruzzi A., et al. Chemokine expression by subchondral bone marrow stromal cells isolated from osteoarthritis (OA) and rheumatoid arthritis (RA) patients. Clin Exp Immunol 1999, 116:371-378.
45. Valverde-Franco G., Pelletier J.P., Fahmi H., Hum D., Matsuo K., Lussier B., et al. Invivo bone-specific EphB4 overexpression in mice protects both subchondral bone and cartilage during osteoarthritis. Arthritis Rheum 2012, 64:3614-3625.
46. Fahlgren A., Messner K., Aspenberg P. Meniscectomy leads to an early increase in subchondral bone plate thickness in the rabbit knee. Acta Orthop Scand 2003, 74:437-441.